Biotech researching psychoactive stocks are well off of their 2020 highs. But they are even further from their 2020 lows. Opportunity knocks.
150x50
VIEW IN BROWSER
Opportunity Knocks In Neuroscience Stocks: A six month review
Here is a quick glance at neuroscience drug stocks' performance these last few months and what stocks investors should be watching! | Find out the details
NYU Is Launching $10M Center for Psychoactive Compounds!
New York University wants to expand our minds in a trippy way. | Find out more
Music And Psilocybin Are Treating Addiction?
Study: Study: When patients trying to quit cigarettes undergo psilocybin treatment, non-classical music has shown to help? | Read more
32x32x1   32x32x2  
TheSeedInvestor.com
9375 E Shea Blvd Ste 100
Scottsdale 85260
info@theseedinvestor.com
 
©2019, All Rights Reserved  |  Unsubscribe   |   View this in Browser

To keep receiving emails from us, please add us to your address book.